Boston-Brazil Collaborative Study of Sickle Cell Disease | NHLBI Trans-Omics for Precision Medicine Skip to main content

Boston-Brazil Collaborative Study of Sickle Cell Disease

Short Name
Boston-Brazil_SCD
Institution(s)
Harvard University
Type of Omics
WGS
Approx. Sample Size 958
Disease/Phenotype
sickle cell disease
Starting Phase
Phase 2
TOPMed Accession #
phs001599
Omics Center(s) Phase 2
Baylor College of Medicine Human Genome Sequencing Center
Omics Center(s) Phase 5
Baylor College of Medicine Human Genome Sequencing Center
Specify the TOPMed Phase for the Omics Center(s) selected above
5.4
Omics Center Contact
Donna Muzny
Phases Involved
2
PI

Vijay G. Sankaran
Contact

Vijay G. Sankaran
Data Set contact(s)
Vijay G. Sankaran
L. A. Liggett
COL Contact(s)
Vijay G. Sankaran
Project
Boston-Brazil_SCD